RxDoctor Payments Data

King Coffield

Urology · Temple, TXNPI 1487614376

Payments from drug & device makers

What this record shows

Pfizer accounts for 85.7% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $1,449 and has fallen 94.1% since, to $86 in 2021. That places this record below the midpoint for urology clinicians in TX, where the typical reported total is $3,394.

$1,627in general payments, 2019–2025

Across 8 payments — averaging $203.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$1K
  • Photocure Inc$97
  • Myriad Genetic Laboratories, Inc.$86
  • Johnson & Johnson$49
$493,246in research payments, 2019–2025

Across 31 payments — averaging $15,911 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$434K
  • E.r. Squibb & Sons, L.L.C.$36K
  • Artivion, Inc.$24K
  • Urovant Sciences Inc$250

What the payments were for

  • Travel & lodging$84352%
  • Food & beverage$78448%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,627 in reported general payments places this provider in the 30th percentile of 878 urology providers in Texas.

See all urology providers in Texas

Other urology in Temple

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →